MYC regulates ductal-neuroendocrine lineage plasticity in pancreatic ductal adenocarcinoma associated with poor outcome and chemoresistance

Amy Farrell(Northeastern University), Rosalie C. Sears(Oregon Health & Science University), Jennifer P. Morton(Cancer Research UK), Zina P. Jenny(Oregon Health & Science University), Nathiya Muthalagu(Indian Institute of Technology Madras), Sara L. Manning(The University of Texas MD Anderson Cancer Center), Patrick J. Worth(Oregon Health & Science University), Christian Lanciault(Oregon Health & Science University), Jason M. Link(Oregon Health & Science University), Erica D. Pratt(The University of Texas MD Anderson Cancer Center), Carl Pelz(Oregon Health & Science University), Nkolika Egbukichi(Oregon Health & Science University), Megan T. Hoffman(Massachusetts Institute of Technology), Andrew D. Rhim(Cancer Research Institute), Brett C. Sheppard(Oregon Health & Science University), Taylor S. Amery(Oregon Health & Science University), Brittany L. Allen-Petersen(Purdue University West Lafayette), Howard C. Crawford(Henry Ford Health System), Meghan M. Joly(UL Research Institutes), Mary C. Thoma(Oregon Health & Science University), Owen J. Sansom(Cancer Research UK), Laura M. Heiser(Oregon Health & Science University), Daniel J. Murphy(Cancer Research UK), David Sauer(Oregon Health & Science University), Nicholas D. Kendsersky(Oregon Health & Science University)
Nature Communications
November 17, 2017
Cited by 159


Related Papers